There is a flurry of news coming up- AGM, FDA meeting, Acadia Q1 earnings (although yearly guidance given), 2 P2 results, potential PRV sale. All catalysts to the SP.
Im particulary interested in the details of the funding for the P3 PM trial and hope we receive some guidance at the AGM however we may not given the FDA meeting would not have occured. How this plays out is likely to guide my decision on whether to hold or sell. My preference is to be taken out so the investment is realised.
Share Price, page-9809
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.09 |
Change
-0.710(3.26%) |
Mkt cap ! $2.693B | |||
| Open | High | Low | Value | Volume |
| $21.74 | $21.78 | $21.03 | $7.303M | 342.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 377 | $21.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.10 | 257 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.16 |
Change
-0.710 ( 3.28 %) |
||||
| Open | High | Low | Volume | ||
| $21.72 | $21.72 | $21.03 | 92331 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| NEU (ASX) Chart |